WebThese recommendations are based on the National Institute for Health and Care Excellence (NICE) guideline Bronchiectasis (non-cystic fibrosis), acute exacerbation: antimicrobial prescribing [NICE, 2024a], the British Thoracic Society (BTS) Guideline for bronchiectasis in adults [], and expert opinion in a narrative review Primary care implications of the British … WebLong-term therapy — monitor liver function and for signs of pulmonary adverse effects, especially in the elderly (discontinue if deterioration in lung function). Chronic pulmonary …
Idiopathic Pulmonary Fibrosis and Lung Cancer: Mechanisms and ... - PubMed
Pulmonary fibrosis is a lung disease that occurs when lung tissue becomes damaged and scarred. This thickened, stiff tissue makes it more difficult for your lungs to work properly. As pulmonary fibrosis worsens, you become progressively more short of breath. The scarring associated with pulmonary … See more Signs and symptoms of pulmonary fibrosis may include: 1. Shortness of breath (dyspnea) 2. A dry cough 3. Fatigue 4. Unexplained weight loss 5. Aching muscles and joints 6. Widening and rounding of the tips … See more Pulmonary fibrosis scars and thickens the tissue around and between the air sacs (alveoli) in your lungs. This makes it more difficult for oxygen to pass into your bloodstream. The damage can be caused by many different … See more Complications of pulmonary fibrosis may include: 1. High blood pressure in your lungs (pulmonary hypertension). Unlike systemic high blood pressure, this condition affects only the arteries in your lungs. It begins when … See more Factors that make you more susceptible to pulmonary fibrosis include: 1. Age.Although pulmonary fibrosis has been diagnosed in children and infants, the disorder is much more likely to affect middle-aged and … See more WebFeb 6, 2024 · This guidance replaces NICE technology appraisal guidance 282 on pirfenidone for treating idiopathic pulmonary fibrosis. Your responsibility. The recommendations in this guidance represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, health … cranfield it helpdesk
Bleomycin Drugs BNF NICE
WebProgressive pulmonary fibrosis Progressive pulmonary fibrosis is dose-related, and may occur at lower doses in the elderly. Suspicious chest X-ray changes are an indication to stop therapy with this drug. Pulmonary toxicity Patients who have received bleomycin may be at risk of developing pulmonary toxicity if exposed to high inspired oxygen ... WebInterstitial lung disease (ILD) Causes — smoking, idiopathic pulmonary fibrosis, sarcoidosis, pneumoconiosis, medication, connective tissue disease, hypersensitivity … WebSome of the more common medication types that are known to carry the risk of pulmonary fibrosis include certain: antibiotics, particularly nitrofurantoin. immunosuppressant drugs, such as methotrexate. drugs for heart conditions, particularly amiodarone. cancer chemotherapy drugs. biological agents used to treat cancer or immune disorders. cranfield ireland genealogy